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1  | INTRODUC TION
Hypertension and obstructive sleep apnea (OSA) are both common 
conditions in the general population. Recent studies have estimated 
30%- 50% of patients with hypertension have OSA which might be 
underestimated, though the prevalence in the PC setting is unclear.1–4
Understanding the prevalence and characteristics of OSA in PC 
patients with hypertension enables us to develop efficient diagnostic 
strategies. These strategies could improve the quality of hypertension 
and sleep disorder management in PC setting. Thus, our study aimed to 
explore the prevalence and characteristics of OSA in patients with hy-
pertension and develop a diagnostic algorithm for unrecognized mod-
erate or severe OSA in patients with hypertension in the PC setting.
2  | MATERIAL S AND METHODS
In this multicenter cross- sectional study, a convenience sample of 
eligible patients (aged 18 years or older and diagnosed with hyper-
tension) was enrolled during visits to one of five clinics in Japan from 
October 2012 to September 2014. We excluded patients who met 
any of the following criteria: already diagnosed with OSA, moderate 
or severe heart failure, chronic obstructive pulmonary disease, or 
dementia.
This study was approved by the ethics committee of Mito Kyodo 
General Hospital and was conducted according to the principles ex-
pressed in the Declaration of Helsinki. Study participants provided 
written informed consent.
2.1 | Data collection
We used medical records to collect data on patients’ character-
istics, which included age, gender, body mass index (BMI), office 
blood pressure, comorbidities (diabetes mellitus, atrial fibrillation, 
ischemic heart disease, and cerebrovascular disease), number of 
antihypertensive drugs, current smoking status, regular alcohol 
use, and regular use of benzodiazepines. Physicians asked the 
patients who agreed to participate in the study if they have fol-
lowing six signs and symptoms: excessive daytime sleepiness; 
non- restorative sleep; fatigue; insomnia; waking up with breath 
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Abstract
Background: As the number of patients with hypertension who have obstructive 
sleep apnea (OSA) might be underestimated, this study aimed to explore the preva-
lence of OSA and develop a diagnostic algorithm for moderate or severe OSA among 
primary care (PC) patients with hypertension.
Methods: This multicenter cross- sectional study enrolled patients diagnosed with 
hypertension aged 18 years or older in Japan from October 2012 to September 2014.
Results: Forty- nine patients (64.5%) had 22 or more obstructive respiratory events 
during sleep.
Conclusions: The prevalence of OSA among PC patients with hypertension might be 
much higher than previously thought.
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holding, gasping, or choking; and habitual snoring, breathing in-
terruptions, or both noted by a bed partner or other observer. 
Subsequently, we assessed AHI and oxygen desaturation index 
(ODI) to obtain the frequency of respiratory events by using home 
sleep apnea testing (HSAT). We defined AHI as the average num-
ber of apneas and hypopneas per hour of sleep and ODI as the 
number of events per hour of recorded time in which blood oxygen 
saturation	fell	by	≥3%.
2.2 | Statistical analysis
We diagnosed OSA according to ICSD- 2 criteria proposed by 
American Academy of Sleep Medicine.5	We	classified	AHI	≥	22	on	
HSAT	as	moderate	or	 severe	OSA	and	22	>	AHI	≥	5	as	mild	OSA	
based on a previous study.6 Differences in characteristics between 
patients who underwent home sleep apnea testing (HSAT) and 
those who did not were compared using Student’s t test for con-
tinuous variables and Pearson’s chi- square test or Fisher’s exact 
test for categorical variables. Subsequently, we developed a diag-
nostic	algorithm	using	nine	variables:	age	(≥50	years	or	<50	years),	
gender,	BMI	≥	27,	office	systolic	blood	pressure	≥140,	office	dias-
tolic	blood	pressure	≥90,	use	of	≥3	antihypertensive	drugs,	current	
smoker, regular alcohol use, and regular use of benzodiazepines, 
for moderate or severe OSA using classification and regression tree 
analysis. P- values were based on two- sided tests and considered 
statistically significant at <0.05. General statistical analyses were 
performed with SPSS version 24.0- J (SPSS- Japan, Tokyo, Japan).
3  | RESULTS
A total of 119 patients met the inclusion criteria, but 42 did not sub-
sequently undergo HSAT and one had missing HSAT data. We devel-
oped the diagnostic algorithm based on data from 76 patients who 
underwent HSAT. Patient characteristics are summarized in Table 1. 
Forty-	nine	patients	 (64.5%)	had	AHI	≥	22,	and	24	patients	 (31.6%)	
had	22	>	AHI	≥	5.	Fifteen	of	32	female	patients	(46.9%)	and	13	of	28	
postmenopausal	female	patients	(46.4%)	had	AHI	≥	22.
The classification and regression tree analysis generated two 
classification splits for the high- risk groups (75% to <90% preva-
lence) and intermediate- risk groups (<75% prevalence) for moderate 
or severe OSA (Figure 1). The high- risk group included male patients, 
and	 female	patients	 taking	≥3	 antihypertensive	drugs.	 Female	pa-
tients	 not	 taking	 ≥3	 antihypertensive	 drugs	 were	 placed	 in	 the	
intermediate- risk group.
4  | DISCUSSION
This is the first multicenter cross- sectional study to explore the 
prevalence and characteristics of OSA and develop a diagnostic al-
gorithm for unrecognized moderate or severe OSA among PC pa-
tients with hypertension.
The most important finding of this study was that 64.5% of pa-
tients	had	AHI	≥	22,	which	fulfills	the	diagnostic	criteria	for	moder-
ate or severe OSA in patients with hypertension.7 This prevalence 
is much higher than in a recent study that estimated the prevalence 
of with hypertension to be 30%- 50%1,4. One possible reason for the 
high prevalence of OSA in PC patients with hypertension is that we 
might have missed patients with hypertension who do not have ob-
vious signs and symptoms of OSA in the PC setting until now. Thus, 
our results imply that many patients with hypertension in the PC set-
ting need to be assessed for obstructive respiratory events during 
sleep.
The second important finding of this study was that we devel-
oped a diagnostic algorithm for unrecognized moderate or severe 
OSA. The diagnostic algorithm indicates that we should pay atten-
tion to detecting moderate or severe OSA in specific patients: male 
patients	with	hypertension,	or	female	patients	taking	≥3	antihyper-
tensive drugs. This algorithm enables us to easily recognize the pa-
tients with hypertension who have a high risk of moderate or severe 
OSA, and accurately recommend HSAT for patients with hyperten-
sion in the PC setting.
Of note that our study revealed that female hypertension pa-
tients have high pretest possibility of moderate or severe OSA. 
This result implies that we should assess the obstructive respira-
tory events for female patients with hypertension as well as male 
patients.
The major limitations of this study were that we enrolled patients 
using convenience sampling, and the number of patients who did not 
undergo HSAT is large in comparison with those eligible in this study, 
though there was no significant difference except for mean age. And 
F IGURE  1 The high- risk group had 
a 75% to <90% prevalence of moderate 
or severe OSA, and the intermediate- 
risk group had a < 75% prevalence of 
moderate or severe OSA
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that this study had a small sample size despite being a multicenter 
study. Therefore, the validation is needed for clinical applications 
and caution is needed when interpreting the results.
5  | CONCLUSION
The prevalence of OSA among PC patients with hypertension might 
be much higher than previously thought. In the PC setting, patients 
with hypertension who have specific risk factors for OSA should un-
dergo assessment for obstructive respiratory events during sleep.
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